CD8A and central nervous system cancer: Flow cytometry of an additional matched glioma grade 4 patient cohort confirmed an increased abundance of CX3CR1+ CD8+ T cells in PBMC compared to almost absent CX3CR1+ CD8+ T cells in tumor periphery (Figure 5C, Figure 5—figure supplement 1A, Supplementary file 1).